Skip to main content

Advertisement

Table 1 Base Case Value and Sensitivity Range Used in the Model

From: Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model

• Transition probabilities • Yearly base-case value (%) • Range (%)
• Age-specific mortality • 7.91 [27] • –
• Rate of disease recurrence without worsening of the disease (LD group) • 4.7 [10, 13] [25, 30] • 3.99 [13]~ 7.05 [10]
• Rate of disease recurrence with worsening of the disease(LD group) • 2.7 [10, 13] [25, 30] • 2.06 [13]~ 5.98 [10]
• Rate of disease recurrence without worsening of the disease(FD group) • 3.3 [4] [10, 26, 30] • 1.55 [26] ~ 4.92 [4]
• Rate of disease recurrence with worsening of the disease(FD group) • 3.7 [4] [10, 26, 30] • 2.35 [26]~ 5.77 [10]
• Mortality of RC surgery • 1.9 [31,32,33] • 1 [33] ~ 5.2 [34]
• Metastatic rate after underwent RC • 2.6 [35, 36] • 2.3 [36] ~ 7.97[35]
• Death rate of metastatic state • 44.1 [37] • 42.99 [37] ~ 50 [38]